Introduction: FOXO4-DRI peptide allows selective apoptosis of senescent cells, supports metabolic reports, and guarantees security in study, improving reproducibility and advancing growing older and oncology investigations. Daily laboratory workflows usually expose gaps where by present compounds fail to address cell senescence comprehensively and